Loading...
Header Logo
Keywords
Last Name
Institution

MARIA KRISTINE GULE-MONROE

TitleAssistant Professor
InstitutionMD Anderson
DepartmentDiagnostic Radiology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wang JR, Zafereo M, Dadu R, Ferrarotto R, Busaidy N, Lu C, Ahmed S, Gule-Monroe M, Williams MD, Sturgis E, Goepfert RP, Gross ND, Lai SY, Gunn B, Phan J, Rosenthal DI, Fuller C, Morrison WH, Iyer PC, Cabanillas M. Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma. Thyroid. 2019 Jul 18. PMID: 31319771.
      View in: PubMed
    2. Jethanandani A, Gule-Monroe MK, Chen M, Johnson JM. Extraneural Metastases From a High-Grade Glioma (HGG) With an H3F3A G34R Mutation. Front Oncol. 2019; 9:373. PMID: 31139567.
      View in: PubMed
    3. Jethanandani A, Chen MM, Gule-Monroe MK, Morrison WH, Lai SY, Johnson JM. Incidental detection of oropharyngeal cancer with fluciclovine PET. Head Neck. 2019 Aug; 41(8):E141-E145. PMID: 31046173.
      View in: PubMed
    4. Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM, Dhar SU. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma. Neurol Genet. 2018 Aug; 4(4):e248. PMID: 30046660.
      View in: PubMed
    5. Iyer PC, Dadu R, Gule-Monroe M, Busaidy NL, Ferrarotto R, Habra MA, Zafereo M, Williams MD, Gunn GB, Grosu H, Skinner HD, Sturgis EM, Gross N, Cabanillas ME. Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma. J Immunother Cancer. 2018 Jul 11; 6(1):68. PMID: 29996921.
      View in: PubMed
    6. Iyer PC, Dadu R, Ferrarotto R, Busaidy NL, Habra MA, Zafereo M, Gross N, Hess KR, Gule-Monroe M, Williams MD, Cabanillas ME. Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma. Thyroid. 2018 01; 28(1):79-87. PMID: 29161986.
      View in: PubMed
    7. Sano D, Gule MK, Rosenthal DI, Bell D, Yates J, El-Naggar AK, Myers JN. Early postoperative epidermal growth factor receptor inhibition: safety and effectiveness in inhibiting microscopic residual of oral squamous cell carcinoma in vivo. Head Neck. 2013 Mar; 35(3):321-8. PMID: 22367702.
      View in: PubMed
    8. Gule MK, Chen Y, Sano D, Frederick MJ, Zhou G, Zhao M, Milas ZL, Galer CE, Henderson YC, Jasser SA, Schwartz DL, Bankson JA, Myers JN, Lai SY. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res. 2011 Apr 15; 17(8):2281-91. PMID: 21220477.
      View in: PubMed
    9. Sano D, Choi S, Milas ZL, Zhou G, Galer CE, Su YW, Gule M, Zhao M, Zhu Z, Myers JN. The effect of combination anti-endothelial growth factor receptor and anti-vascular endothelial growth factor receptor 2 targeted therapy on lymph node metastasis: a study in an orthotopic nude mouse model of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg. 2009 Apr; 135(4):411-20. PMID: 19380367.
      View in: PubMed
    GULE-MONROE's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description